Pharmaceutical Filtration Market worth 20,190.1 M USD by 2020, According to a New Study on ASDReports

Tuesday 16 February 2016, Amsterdam

The report, now available on ASDReports, "Pharmaceutical Filtration Market by Product (Membrane Filters, Single-use systems), Techniques (Ultrafiltration, Cross Flow Filtration), Applications, Scale of Operations, Geography (North America, Europe) - Global Forecast to 2020" , report provides a detailed overview of the major drivers, restraints, opportunities, challenges and trends impacting the global pharmaceutical filtration market along with the estimates and forecasts of the revenue and market share analysis.

The global pharmaceutical filtration market is expected to reach USD 20,190.1 Million by 2020 from USD 12,451.3 Million in 2015, growing at a CAGR of 10.2%. Growth of biopharmaceutical industry, advancements in nanofiber technology, rapid expansion in generic drug production, increasing incidence of airborne disease, and strong biologics product pipeline, are the primary growth drivers for this market. However, stringent government regulations for validation of filtration process and cost constraints related to adoption of membrane filters are restraining the growth of this market.

The global pharmaceutical filtration market is segmented on the basis of products, techniques, applications, scale of operations. On the basis of products, the market is segmented into membrane filters, prefilters & depth media, cartridges & capsules, single-use systems, filter holders, filtration accessories. Of these, the membrane filters product segment accounted for the largest share of the global pharmaceutical filtration market in 2015.

By techniques, the market is divided into microfiltration, ultrafiltration, cross flow filtration, and, nanofiltration. Of these, the microfiltration forms the fastest-growing technique segment in the global pharmaceutical filtration market by 2020. On the basis of applications, the pharmaceutical filtration market is categorized into final product processing, raw material filtration, cell separation, water purification, and air purification. Of these, the pharmaceutical final product was the largest and fastest-growing application segment in 2015 and active pharmaceutical ingredients (APIs) accounted for the major share of global final product application segment in 2015.

The geographic segments included in this report are North America, Europe, Asia, and Rest of the World (RoW).

The major players in this market include Merck & Co., Inc. (U.S.), General Electric Company (U.S.), Pall Corporation (U.S.), Parker Hannifin Corporation (U.S.), Sartorius Stedim Biotech Group (France), and 3M (U.S.), Eaton Corporation Plc. (Ireland), Amazon Filters Ltd. (United Kingdom), Graver Technologies, LLC. (U.S.), and Meissner Filtration Products, Inc. (U.S.).